Tenon Medical Ups ATM Capacity to $7.18M, Discloses $2.81M Already Sold
TNON is trading near its 52-week low of $2.4 (13% above the low).
Summary
Tenon Medical amended its ATM prospectus to raise the maximum offering to $7,176,045, after already selling $2,809,378 under the program. The added capacity extends a dilutive drip-feed of shares for a company with going-concern doubt and limited cash runway.
Key Events · Financing and Capital Events · TNON
-
ATM Capacity Raised to $7.18M
Prospectus supplement increases the maximum aggregate offering price under the ATM Sales Agreement with A.G.P. to $7,176,045, excluding the $2,809,378 already sold.
-
$2.81M Already Sold Under ATM
Tenon discloses it has sold $2,809,378 of common stock under the ATM in the 12 months prior to this supplement, confirming the program is actively being used.
-
Public Float Caps S-3 Capacity
Non-affiliate public float is $29,956,270 (2,625,440 shares at $11.41, the August 19, 2026 closing price), limiting primary sales to one-third of float under General Instruction I.B.6.
-
Dilution Against Going-Concern Backdrop
The added ATM capacity follows previously disclosed going-concern doubt, a material weakness in controls, and less than 12 months of cash runway, making the raise a funding necessity rather than opportunistic.
Analysis · TNON · Industrial Applications And Services
Tenon is expanding its at-the-market program to $7,176,045 of common stock, on top of the $2,809,378 it has already sold under the same sales agreement. The company is doing this because its public float of $29.96M caps how much it can raise under Form S-3's one-third limit — it has essentially exhausted the prior $4.4M capacity and is resetting the ceiling. For a company that previously disclosed going-concern doubt, a material weakness in controls, and less than 12 months of cash runway, this is survival capital: it keeps the lights on, but every share sold drips into a stock that trades at $2.70 versus the $2.91 last reported sale price on October 15, 2026. The ATM is a persistent overhang rather than a one-time dilution event, and the company gets to choose the pace of sales.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 29.5% of the 1476 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TNON was trading at $2.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $2.40 to $50.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.